Mechanisms of Transdermal Controlled Nitroglycerin Administration (I): Development of a Finite-Dosing Skin Permeation System

A new finite-dosing cell for in vitro skin permeation studies was recently developed to overcome the deficiencies observed in the commercially available Franz diffusion cell and to accomplish the solution hydrodynamics and temperature control required in studying the rate profiles of skin permeation.

Results of comparative studies indicated that the improved diffusion cell, named Keshary-Chien diffusion cell, can achieve and maintain the target body temperature on the skin surface and in the receptor solution, which cannot be accomplished by the Franz diffusion cell. Solution mixing efficiency was substantially improved, so the drug distribution and concentration homogeneity could be achieved in the Keshary-Chien diffusion cell within a duration four times shorter than in the Franz diffusion cell; and a 3-fold reduction in the thickness of the hydrodynamic boundary layer was achieved, so the effect of mass transfer in the hydrodynamic boundary layer on the skin permeation rate profiles was minimized.